CATALOGO DEI PRODOTTI DELLA RICERCA

PEA, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.377
EU - Europa 4.355
AS - Asia 3.056
SA - Sud America 526
Continente sconosciuto - Info sul continente non disponibili 225
AF - Africa 102
OC - Oceania 13
Totale 13.654
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.091
RU - Federazione Russa 1.821
SG - Singapore 1.205
CN - Cina 809
IT - Italia 691
GB - Regno Unito 622
BR - Brasile 425
VN - Vietnam 293
HK - Hong Kong 275
DE - Germania 247
SE - Svezia 197
IE - Irlanda 196
FR - Francia 183
CA - Canada 134
FI - Finlandia 120
KR - Corea 84
BD - Bangladesh 83
IN - India 66
MX - Messico 56
JP - Giappone 55
NL - Olanda 54
UA - Ucraina 34
AR - Argentina 31
ES - Italia 31
ZA - Sudafrica 29
AT - Austria 27
TR - Turchia 26
ID - Indonesia 25
PL - Polonia 22
PK - Pakistan 21
IQ - Iraq 20
EC - Ecuador 19
BE - Belgio 17
CH - Svizzera 16
CO - Colombia 14
CR - Costa Rica 14
HN - Honduras 14
VE - Venezuela 14
SV - El Salvador 11
TG - Togo 11
UZ - Uzbekistan 11
AU - Australia 10
BJ - Benin 10
CZ - Repubblica Ceca 10
NG - Nigeria 10
MA - Marocco 9
AZ - Azerbaigian 8
CW - ???statistics.table.value.countryCode.CW??? 8
EG - Egitto 8
JO - Giordania 8
SA - Arabia Saudita 8
TT - Trinidad e Tobago 8
CL - Cile 7
IL - Israele 7
JM - Giamaica 7
PH - Filippine 7
PR - Porto Rico 7
PT - Portogallo 7
SI - Slovenia 7
BS - Bahamas 6
LV - Lettonia 6
NI - Nicaragua 6
TN - Tunisia 6
BB - Barbados 5
GT - Guatemala 5
KE - Kenya 5
KZ - Kazakistan 5
NO - Norvegia 5
PE - Perù 5
AM - Armenia 4
BO - Bolivia 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
EE - Estonia 4
GR - Grecia 4
HR - Croazia 4
HU - Ungheria 4
LT - Lituania 4
MY - Malesia 4
OM - Oman 4
PS - Palestinian Territory 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
IR - Iran 3
KG - Kirghizistan 3
NP - Nepal 3
PY - Paraguay 3
RS - Serbia 3
SC - Seychelles 3
BG - Bulgaria 2
CY - Cipro 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
GP - Guadalupe 2
SN - Senegal 2
TH - Thailandia 2
Totale 13.415
Salva come PNG Salva come JPEG
Città #
Moscow 676
Singapore 665
Ashburn 660
San Jose 563
Dallas 550
Southend 461
Chandler 456
Verona 308
Hong Kong 270
New York 196
Council Bluffs 188
Dublin 178
Beijing 161
The Dalles 130
Ho Chi Minh City 102
Los Angeles 102
Santa Clara 90
Munich 87
Jacksonville 81
Woodbridge 68
Ann Arbor 67
Hanoi 65
Houston 65
Milan 58
Princeton 56
Helsinki 55
Lawrence 55
São Paulo 51
Redmond 49
Wilmington 48
Tokyo 47
Columbus 42
Buffalo 40
London 38
Redondo Beach 38
Denver 34
Montreal 34
Nanjing 34
Jinan 33
Shenyang 32
Sindelfingen 31
Brooklyn 30
Orem 30
Turku 28
Mexico City 27
Washington 25
Atlanta 24
Phoenix 24
Toronto 23
Amsterdam 22
Ningbo 22
Frankfurt am Main 21
Seattle 21
Johannesburg 20
Poplar 20
Guangzhou 19
Chennai 18
Hebei 18
Stockholm 18
Chicago 17
Hangzhou 17
Rio de Janeiro 17
Rome 17
Taizhou 17
Brussels 16
Tianjin 16
Warsaw 16
Da Nang 15
Lappeenranta 15
Changsha 14
Haikou 14
Madrid 14
McKinney 14
North Bergen 14
Seoul 14
Taiyuan 14
Zhengzhou 14
Zurich 14
Barnet 13
Bologna 13
Boston 13
Manchester 13
Nuremberg 13
Vienna 13
Belo Horizonte 12
Falkenstein 12
Menlo Park 12
Paris 12
Shanghai 12
Brasília 11
Fairfield 11
Kent 11
Lomé 11
Mumbai 11
Redwood City 11
San Francisco 11
San José 11
Abuja 10
Brno 10
Charlotte 10
Totale 7.919
Salva come PNG Salva come JPEG
Nome #
Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis 308
Genomic characterization of hepatoid tumors: context matters 277
Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas 243
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 236
CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas 229
Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis 223
Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis 219
Different Prognostic Roles Of Tumor Suppressor Gene BAP1 In Cancer: A Systematic Review With Meta-Analysis 216
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 215
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 212
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experience 211
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 210
Ampulla of Vater carcinoma: Molecular landscape and clinical implications 209
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 206
Ablation treatments in unresectable pancreatic cancer 203
Clinical Implications of the 2016 International Study Group on Pancreatic Surgery Definition and Grading of Postoperative Pancreatic Fistula on 775 Consecutive Pancreatic Resections 202
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 200
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 199
A randomized controlled trial of stapled versus ultrasonic transection in distal pancreatectomy 198
Endoscopic placement of pancreatic stent for "Deep" pancreatic enucleations operative technique and preliminary experience at two high-volume centers 192
Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis 192
Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma 191
Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors 190
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 189
Pancreaticojejunostomy after pancreaticoduodenectomy: Suture material and incidence of post-operative pancreatic fistula 185
Pancreatoduodenectomy at the Verona Pancreas Institute: the Evolution of Indications, Surgical Techniques and Outcomes: A Retrospective Analysis of 3000 Consecutive Cases 183
Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study 180
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 179
An Antibiotic Stewardship Program in Pancreatic Surgery 179
Extranodal extension in N1-adenocarcinoma of the pancreas and papilla of Vater: a systematic review and meta-analysis of its prognostic significance 178
Loss of FGFR4 promotes the malignant phenotype of PDAC 177
Long term outcome after minimally invasive and open Warshaw and Kimura techniques for spleen-preserving distal pancreatectomy: International multicenter retrospective study 176
Combinatorial Effect of Magnetic Field and Radiotherapy in Pancreatic Ductal Adenocarcinoma Organoids 175
Endoscopic ultrasound fine-needle biopsy to assess DAXX/ATRX expression and alternative lengthening of telomeres status in non-functional pancreatic neuroendocrine tumors 174
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 174
Extranodal extension is an important prognostic parameter for both colonic and rectal cancer 171
401 consecutive minimally invasive distal pancreatectomies: lessons learned from 20 years of experience 170
Platinum-Based Treatment for Well- and Poorly Differentiated Pancreatic Neuroendocrine Neoplasms 167
Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characterization 166
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases 165
Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis 163
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 163
Histo-molecular characterization of pancreatic cancer with microsatellite instability: intra-tumor heterogeneity, B2M inactivation, and the importance of metastatic sites 163
Exploring chatbot applications in pancreatic disease treatment: potential and pitfalls 161
Artificial intelligence in oncology: current applications and future perspectives 158
Fatty pancreas disease: an integrated study on frozen tissues shows distinct compartments of inter/intra-lobular, intra-acinar, and intra-islet fat deposition 158
Long-term organoid culture of a small intestinal neuroendocrine tumor 156
Circulating tumour DNA: a challenging innovation to develop "precision onco-surgery" in pancreatic adenocarcinoma 156
An Antimicrobial Stewardship Program in Pancreatic Surgery Reduces the Infectious Risk of Colonized Bile, Reducing the Predictive Value of the Intraoperative Bile Culture - A Before-after Study on 1638 Pancreatoduodenectomies 153
Negative pressure wound therapy for prevention of surgical site infection in patients at high risk after clean-contaminated major pancreatic resections: A single-center, phase 3, randomized clinical trial 152
Pancreatic surgery during COVID-19 pandemic: major activity disruption of a third-level referral center during 2020 152
Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary 149
Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas 147
Comprehensive characterization of intraductal oncocytic papillary neoplasm of the pancreas: a systematic and critical review 145
Prognostic impact and implications of extra-capsular lymph node involvement in colorectal cancer: a systematic review with meta-analysis 140
Morphologic Characterization of Pancreatic Ductal Adenocarcinoma following Post-neoadjuvant Pancreatectomy and Clinical value of Intratumor Heterogeneity 138
Impact of COVID-19 on Pancreatic Cancer Research and the Path Forward 138
Thirty-day prevalence and clinical impact of fluid collections at the resection margin after distal pancreatectomy: Follow-up of a multicentric randomized controlled trial 135
Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring 135
Significance of the prognostic stratification of extranodal extension in colorectal cancer 134
Molecular Subtyping and Precision Medicine for Pancreatic Cancer 134
Characterization and digital spatial deconvolution of the immune microenvironment of intraductal oncocytic papillary neoplasms (IOPN) of the pancreas 133
Histo-molecular oncogenesis of pancreatic cancer: From precancerous lesions to invasive ductal adenocarcinoma 131
Whole-exome sequencing of duodenal neuroendocrine tumors in patients with neurofibromatosis type 1 130
Molecular and clinical patterns of local progression in the pancreatic remnant following resection of pancreatic intraductal papillary mucinous neoplasm (IPMN) 129
Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis 125
PBRM1 loss is a late event during the development of cholangiocarcinoma 117
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size 115
Biology and clinical application of regulatory RNAs in hepatocellular carcinoma 113
Pancreatic resections for cystic neoplasms: from the surgeon's presumption to the pathologist's reality 108
Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence 104
Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cells 104
Neuroendocrine Neoplasms of the Digestive System 103
Resection to Exploration Ratios and Associated Outcomes in Patients with Pancreatic Ductal Adenocarcinoma 99
The Impact of Molecular Subtyping on Pathological Staging of Pancreatic Cancer 94
Genomic characterization of malignant progression in neoplastic pancreatic cysts 91
Progression of Intraductal Papillary Mucinous Neoplasms (IPMN) is possible after 5 years of follow-up 85
Solid Pseudopapillary Neoplasm of the Pancreas: EUS Features and Diagnostic Accuracy of EUS-Guided Fine Needle Biopsy Using a 22-Gauge Fork-Tip Needle in a High Volume Center 84
Surgical and Oncological Outcomes of Minimally Invasive Left Pancreatectomy for Pancreatic Cancer: Robotic vs. Laparoscopic Approach 78
Contact system and intrinsic pathway activation in patients with advanced pancreatic cancer: a prospective cohort study 67
Dissecting the molecular landscape of pancreatic cancer: towards a precision medicine approach 67
The importance of tumor microenvironment modulations in the progression of pancreatic intraductal papillary mucinous neoplasms† 53
Simple mucinous cysts of the pancreas: Clinical and imaging findings - Case series and systematic review of the literature 50
Clonal evolutionary analysis reveals patterns of malignant transformation of Intraductal Papillary Mucinous Neoplasms of the pancreas 46
Survival After Pancreatic Resection for Intraductal Papillary Mucinous Neoplasm: Supporting Selective Surgery 41
Minimally invasive Distal Pancreatectomy eRgonOMic analysis - the DP-ROM trial: An explorative, prospective, observational, cohort study trial 41
Postoperative Fluid Collections Following Left Pancreatectomy: Urgent Need for a Standardized Definition. A Systematic Review and Meta-Analysis 39
Through-the-Needle Biopsy Revisited: How Patient Selection and Standardization Reduce Adverse Events in Pancreatic Cyst Evaluation 39
Cancer Risk After Initial Surveillance of Intraductal Papillary Mucinous Neoplasms (IPMNs): Are We Missing the Window for Prevention? 37
A compendium of next-generation patient-derived models for diverse cancers 32
Intraductal Papillary Squamous Neoplasm (IPSN) of the Pancreas: Histologic and Molecular Characterization of a Novel and Distinct Intraductal Cancer Precursor 28
Multi-omic profiles of neuroendocrine neoplasms of the pancreas: an integrated landscape 20
The Modified Frailty Index Predicts Failure-to-Rescue Mortality After Pancreatoduodenectomy: A Comparison of the 11-Item and 5-Item Versions 15
Real-World-Feasible Immunohistochemistry of ATRX, DAXX, and Menin Identifies a Subgroup of Non-Functioning Pancreatic Neuroendocrine Tumors with low Recurrence Risk to Guide De-Escalating Surveillance 14
Open Total Pancreatectomy With Modified Cattell-Imanaga Reconstruction: How Do We Do It? 14
Clonal evolutionary analysis reveals patterns of malignant transformation in pancreatic cancer from Intraductal Papillary Mucinous IPMN Neoplasms (IPMN) 9
Totale 13.654
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.202
article - articoli 48.198
book - libri 0
conference - conferenze 751
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 253
Totale 98.404
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022285 0 0 0 0 23 18 12 45 34 16 31 106
2022/20231.205 70 147 89 239 84 284 22 77 132 15 31 15
2023/2024750 26 59 69 87 81 142 43 34 6 42 129 32
2024/20251.854 81 90 90 293 91 64 150 105 231 130 202 327
2025/20266.707 406 389 542 1.038 1.655 421 515 414 551 427 151 198
2026/20271.335 87 234 244 698 72 0 0 0 0 0 0 0
Totale 13.654